STOCK TITAN

Enfusion To Present at the 43rd Annual William Blair Growth Stock Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)-- Enfusion, Inc. (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion’s Chief Executive Officer, Oleg Movchan, and Chief Financial Officer, Bradley Herring, will participate at William Blair’s 43rd Annual Growth Stock Conference on Tuesday, June 6, 2023 at 8:00 am CT / 9:00 am ET.

A live audio webcast and archived replay of the event will be available in the Events & Presentations section of the Enfusion Investor Relations website at http://ir.enfusion.com.

About Enfusion

Enfusion's investment management software-as-a-service (SaaS) platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one cloud-native system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence, boosting agility, and powering growth. Enfusion partners with over 800 investment managers from 10 global offices spanning four continents.

Source: Enfusion, Inc.
Source Code: ENFN-IR
ENFN-CORP

Investors

Ignatius Njoku

investors@enfusion.com

Media

media@enfusion.com

Source: Enfusion, Inc.

Enfusion Inc

NYSE:ENFN

ENFN Rankings

ENFN Latest News

ENFN Stock Data

Software Publishers
Information
Link

About ENFN

enfusion is the leading provider of a cloud-based portfolio management and risk system. headquartered in chicago, illinois, with a branch office in new york, new york, and wholly-owned subsidiaries in london and hong kong, enfusion is a software company that focuses on delivering innovative solutions for clients in the financial services industry. our clients across the globe rely on our innovative real-time performance, risk calculations and accounting for some of the most sophisticated financial products. enfusion is undergoing exceptional growth and currently serves some of the world's largest and respected hedge funds with over 90 billion dollars of assets under management.